Oct. 25, 2022 A new approach to cancer immunotherapy that uses one type of immune cell to kill another -- rather than directly attacking the cancer -- provokes a robust anti-tumor immune response that shrinks ...
Oct. 12, 2022 Observing how cells are organised in mucinous ovarian cancer can lead to new treatment options, study ...
Sep. 13, 2022 Researchers have developed a promising, first-of-its-kind messenger RNA therapy for ovarian cancer as well as cachexia, a muscle-wasting condition associated with cancer and other chronic ...
May 4, 2022 Researchers share the identification of a new potential target for CAR T cells called OR2H1 that they have demonstrated inhibits growth in lung and ovarian ...
Apr. 14, 2022 Researchers want to improve their understanding of the immune environment in ovarian cancer in hopes of making immunotherapy an option for these patients. Researchers now report on key ...
Mar. 30, 2022 Researchers have found that treatment with miR-634 reduces the resistance of oral squamous cell carcinoma cells to cisplatin, resulting in increased tumor cell killing. An ointment containing miR-634 ...
Mar. 22, 2022 The appearance of ovarian lesions on ultrasound is an effective predictor of cancer risk that can help women avoid unnecessary surgery, according to a new ...
Mar. 16, 2022 A research team has discovered novel metabolic mechanisms that contribute to how ovarian cancer escapes from immune attack, and how combination therapies can exploit these pathways to improve ovarian ...
Mar. 15, 2022 Researchers have demonstrated a genetic link between endometriosis and ovarian cancer subtypes enabling them to identify potential drug targets for therapy and increasing the understanding of both ...
Mar. 8, 2022 Women who have had one ovary surgically removed (unilateral oophorectomy) are less likely to become pregnant after in vitro fertilization and give birth to fewer babies than women with both ovaries. ...
Feb. 23, 2022 A discovery made in a new study helps to identify poor response tumors already prior chemotherapy is applied and opens new avenues for the development of combination ...
Feb. 14, 2022 A new study shows ixabepilone plus bevacizumab (IXA+BEV) is a well-tolerated, effective combination for treatment of platinum/taxane-resistant ovarian cancer compared to ixabepilone (IXA) ...
Feb. 11, 2022 Researchers discovered how ovarian cancer hides from the body's immune system. The findings will help develop novel precision therapies for ovarian cancer, a common and aggressive cancer ...
Sep. 21, 2021 Mutations in the ARID1A gene are present in more than 50% of ovarian clear cell carcinomas (OCCC), for which effective treatments are lacking. Scientists discovered that loss of ARID1A function ...
Aug. 5, 2021 A gene called DOT1L appears to play a role in progression and severity of ovarian cancer, and inhibitors of the DOT1L enzyme may offer a new therapeutic approach for the disease, researchers say in a ...
Aug. 3, 2021 A key element to slowing metastasis in ovarian cancer is understanding the mechanisms of how tumor cells invade tissues. Biophysics researchers explain how microscopic defects in how healthy cells ...
July 29, 2021 Researchers report the identification of a new target for the PARP inhibitor drug talazoparib and show that combination treatment with talazoparib and the WEE1 inhibitor adavosertib results in ...
July 23, 2021 Researchers are pushing organ-on-a-chip devices to new levels that could change the way clinicians approach cancer treatment, particularly ovarian ...
June 1, 2021 An odor-based test that sniffs out vapors emanating from blood samples was able to distinguish between benign and pancreatic and ovarian cancer cells with up to 95% ...